Pages that link to "Q30664109"
Jump to navigation
Jump to search
The following pages link to Optimization of the relaxivity of MRI contrast agents: effect of poly(ethylene glycol) chains on the water-exchange rates of Gd(III) complexes (Q30664109):
Displaying 26 items.
- Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity (Q24863049) (← links)
- Lanthanide probes for bioresponsive imaging (Q27000361) (← links)
- Design of ProCAs (protein-based Gd(3 ) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers (Q28235682) (← links)
- Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers (Q28283802) (← links)
- Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agent (Q30576125) (← links)
- Modulating water-exchange rates of lanthanide(III)-containing polyaminopolycarboxylate-type complexes using polyethylene glycol (Q30616187) (← links)
- Strategies for optimizing water-exchange rates of lanthanide-based contrast agents for magnetic resonance imaging (Q30660032) (← links)
- High relaxivity Mn(2 )-based MRI contrast agents. (Q30868530) (← links)
- Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules. (Q31062213) (← links)
- Synthesis and characterization of a novel paramagnetic macromolecular complex [Gd(TTDASQ-protamine)]. (Q33262326) (← links)
- Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents (Q33463644) (← links)
- Toward the Design of MR Agents for Imaging β-Cell Function. (Q33649688) (← links)
- Coupling fast water exchange to slow molecular tumbling in Gd3 chelates: why faster is not always better (Q34809764) (← links)
- A (Fluoroalkyl)Guanidine Modulates the Relaxivity of a Phosphonate-Containing T1-Shortening Contrast Agent (Q35458246) (← links)
- A bidentate terephthalamide ligand, TAMmeg, as an entry into terephthalamide-containing therapeutic iron chelating agents (Q35486300) (← links)
- EuII-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging (Q35665118) (← links)
- Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents. (Q43063011) (← links)
- Synthesis and relaxivity studies of a DOTA-based nanomolecular chelator assembly supported by an icosahedral closo-B₁₂²⁻ core for MRI: a click chemistry approach. (Q45814502) (← links)
- Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer (Q47602413) (← links)
- Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications. (Q52682401) (← links)
- Synthesis and Characterization of Ligands and their Gadolinium(III) Complexes (Q57340454) (← links)
- Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents (Q57376627) (← links)
- Structure, Dynamics, and Computational Studies of Lanthanide-Based Contrast Agents (Q57391311) (← links)
- Lanthanide-Based Conjugates as Polyvalent Probes for Biological Labeling (Q60319137) (← links)
- Influence of Molecular Mobility on Contrast Efficiency of Branched Polyethylene Glycol Contrast Agent (Q60921505) (← links)
- Preparation and Properties of Tumor-Targeting MRI Contrast Agent Based on Linear Polylysine Derivatives (Q64252823) (← links)